HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.

AuthorsP Hurteloup, P Chollet, H Roche, B Chevallier, P Cappelaere, M Van Glabbece, M Hayat, J P Armand
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 25 Issue 6 Pg. 995-6 (Jun 1989) ISSN: 0277-5379 [Print] England
PMID2753061 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Doxorubicin
  • esorubicin
Topics
  • Adult
  • Aged
  • Antibiotics, Antineoplastic (therapeutic use)
  • Carcinoma, Renal Cell (drug therapy)
  • Doxorubicin (analogs & derivatives, therapeutic use)
  • Drug Evaluation
  • Female
  • Humans
  • Kidney Neoplasms (drug therapy)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: